Beyond research summary
An added ingredient deserves its own question.
Nianyi Li and colleagues · 2020 · JAMA Network Open
Human · randomized equivalence trial
An original Beyond research note—not the original publication, a patient recommendation or an agency endorsement.
The question
Does adding vitamin C to oral iron improve treatment response compared with the same iron treatment alone? The study examined adults with iron deficiency anaemia, rather than healthy people choosing a dietary supplement.
How they approached it
The investigators randomized 440 adults to oral iron alone or oral iron with vitamin C in an open-label, single-center equivalence trial. A defined comparison helps isolate the contribution of an added ingredient within that treatment setting.
What was measured?
The primary comparison was change in haemoglobin after two weeks. Serum ferritin over follow-up and adverse events provided additional information. These are treatment-response, iron-store and safety observations—not a direct isotope measurement of the fraction of a dose absorbed.
What the study found
The trial found equivalent haemoglobin responses for the two regimens within its predefined equivalence framework. It did not find a significant difference in ferritin change at eight weeks or adverse-event rates. The findings question whether routine added vitamin C was necessary in that specific treatment setting.
What we can conclude
An ingredient’s biochemical rationale is worth testing against a clear comparator. A clinical response can answer a treatment question without revealing the exact absorption mechanism that produced it.
Where the limits sit
The study was open-label and conducted at one center in a particular patient population. It does not mean vitamin C never affects nonheme iron absorption in meals, or that every oral iron regimen behaves identically. It tested neither phosphopeptides nor Beyond Iron+.
Relevance to Beyond
A hypothesis, read in context.
The study is a useful design example for asking what an added ingredient contributes. Beyond’s proposed peptide-versus-same-iron comparison remains a research question, with protocol, endpoint, feasibility and required approvals still to be finalized. This unrelated clinical trial is not proof of our hypothesis.
Source & bibliography
The original belongs to its publisher.
Li, N., Zhao, G., Wu, W., et al. (2020). The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial. JAMA Network Open, 3(11), e2023644.
DOI: 10.1001/jamanetworkopen.2020.23644
This page contains Beyond’s original interpretation only. The publication or agency resource is not hosted or reproduced here. Access to the original may depend on the publisher.
Open original study (opens in a new tab)Keep exploring
Different sources. Different questions.
Authoritative review · nutrition and clinical context
Research note: NIH ODS · iron in contextLaboratory · intestinal-cell model
Research note: Feng & Mine · iron uptake in cellsAgency guidance · advertising substantiation
Research note: FTC · evidence behind health claims